1h Free Analyst Time
The vertigo drugs market is forecasted to grow by USD 561.8 million during 2023-2028, accelerating at a CAGR of 5.44% during the forecast period. The report on the vertigo drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for vertigo drugs in emerging economies, increasing healthcare facilities in developing nations, and increased penetration of online channels.
The vertigo drugs market is segmented as below:
By Type
- Peripheral vertigo
- Central vertigo
By Distribution Channel
- Offline
- Online
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the vertigo drugs market covers the following areas:
- Vertigo drugs market sizing
- Vertigo drugs market forecast
- Vertigo drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global vertigo drugs market: AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of digital health solutions in vertigo."
According to the report, one of the major drivers for this market is the rising demand for vertigo drugs in emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma
- Altamira Therapeutics Ltd.
- Amneal Pharmaceuticals Inc.
- Endo International Plc
- Epic Pharma LLC
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Indicus Pharma
- Intas Pharmaceuticals Ltd.
- Jubilant Pharmova Ltd.
- Lupin Ltd.
- Novartis AG
- Otonomy Inc.
- Pfizer Inc.
- Sensorion
- Sound Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Suven Life Sciences Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
